Rockwell Medical Signs $125M M&A Deal with Vantive Limited
Rockwell Medical has entered into a definitive agreement to acquire Vantive Limited's global in-center hemodialysis business for a base purchase price of $125 million. The acquisition includes manufacturing facilities in Italy, operations in 35 jurisdictions, and a product portfolio spanning concentrates, machines, and water treatment systems. The deal is expected to transform Rockwell into a global provider with projected annual revenues between $400 million and $450 million.
- Value
- $125M
- Counterparty
- Vantive Limited
“Acquiring Vantive’s hemodialysis assets and associated operations represents a transformative step in Rockwell Medical’s evolution and directly advances the strategy we have been executing over the past several years.”
Mark Strobeck, Ph.D., President and Chief Executive Officer at Rockwell Medical